Isao Tachibana

3.7k total citations
91 papers, 2.7k citations indexed

About

Isao Tachibana is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Isao Tachibana has authored 91 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Pulmonary and Respiratory Medicine, 38 papers in Oncology and 21 papers in Molecular Biology. Recurrent topics in Isao Tachibana's work include Lung Cancer Treatments and Mutations (21 papers), Lung Cancer Research Studies (17 papers) and Cell Adhesion Molecules Research (14 papers). Isao Tachibana is often cited by papers focused on Lung Cancer Treatments and Mutations (21 papers), Lung Cancer Research Studies (17 papers) and Cell Adhesion Molecules Research (14 papers). Isao Tachibana collaborates with scholars based in Japan, United States and China. Isao Tachibana's co-authors include Martin E. Hemler, Ichiro Kawase, Tadashi Osaki, Takashi Kijima, Yoshito Takeda, Hiroshi Kida, Toru Kumagai, Mitsuhiro Yoshida, Seiji Hayashi and Sho Goya and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and The Journal of Cell Biology.

In The Last Decade

Isao Tachibana

88 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Isao Tachibana Japan	29	1.0k	787	708	528	416	91	2.7k
Robert Salomon United States	29	1.2k 1.2×	366 0.5×	432 0.6×	632 1.2×	229 0.6×	67	3.7k
Yoshito Takeda Japan	22	614 0.6×	619 0.8×	581 0.8×	370 0.7×	368 0.9×	113	2.0k
Loren Joseph United States	36	1.4k 1.4×	402 0.5×	835 1.2×	406 0.8×	144 0.3×	75	3.2k
R G Crystal United States	28	1.3k 1.2×	991 1.3×	538 0.8×	518 1.0×	237 0.6×	48	3.4k
Renate Kain Austria	32	2.6k 2.6×	1.4k 1.8×	888 1.3×	1.1k 2.1×	451 1.1×	117	5.4k
G. Kenneth Haines United States	29	1.0k 1.0×	280 0.4×	465 0.7×	808 1.5×	523 1.3×	68	3.0k
Brice Korkmaz France	28	861 0.8×	550 0.7×	523 0.7×	1.2k 2.3×	512 1.2×	71	2.9k
Nathalie Heuzé‐Vourc'h France	31	896 0.9×	856 1.1×	644 0.9×	692 1.3×	112 0.3×	94	2.9k
Karim Vermaelen Belgium	27	670 0.7×	869 1.1×	546 0.8×	1.5k 2.9×	214 0.5×	60	3.0k
Karen Toy United States	16	890 0.9×	212 0.3×	752 1.1×	1.1k 2.1×	322 0.8×	18	2.6k

Countries citing papers authored by Isao Tachibana

Since Specialization

Citations

This map shows the geographic impact of Isao Tachibana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isao Tachibana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isao Tachibana more than expected).

Fields of papers citing papers by Isao Tachibana

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isao Tachibana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isao Tachibana. The network helps show where Isao Tachibana may publish in the future.

Co-authorship network of co-authors of Isao Tachibana

This figure shows the co-authorship network connecting the top 25 collaborators of Isao Tachibana. A scholar is included among the top collaborators of Isao Tachibana based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isao Tachibana. Isao Tachibana is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kadota, Kazunori, Koichí Matsumoto, Hiromasa Uchiyama, et al.. (2022). In silico evaluation of particle transport and deposition in the airways of individual patients with chronic obstructive pulmonary disease. European Journal of Pharmaceutics and Biopharmaceutics. 174. 10–19. 26 indexed citations

Yanagisawa, Atsushi, et al.. (2022). Metastatic Lung Tumors from Colorectal Cancer with <i>EGFR</i> Mutations That Responded to Osimertinib. Internal Medicine. 62(5). 769–773. 3 indexed citations

Kinehara, Yuhei, et al.. (2020). Successful continuous nivolumab therapy for metastatic non‐small cell lung cancer after local treatment of oligometastatic lesions. Thoracic Cancer. 11(8). 2357–2360. 5 indexed citations

Kinehara, Yuhei, et al.. (2019). Neuropsychiatric Immune-related Adverse Events Induced by Pembrolizumab in a Patient with Lung Adenocarcinoma and Systemic Lupus Erythematosus. Internal Medicine. 59(4). 569–572. 9 indexed citations

Takeda, Yoshito, Mayumi Suzuki, Yingji Jin, & Isao Tachibana. (2015). Preventive Role of Tetraspanin CD9 in Systemic Inflammation of Chronic Obstructive Pulmonary Disease. American Journal of Respiratory Cell and Molecular Biology. 53(6). 751–760. 9 indexed citations

Tetsumoto, Satoshi, Takashi Kijima, Eiichi Morii, et al.. (2013). Echinoderm Microtubule-Associated Protein-Like 4 (EML4)–Anaplastic Lymphoma Kinase (ALK) Rearrangement in Congenital Pulmonary Airway Malformation. Clinical Lung Cancer. 14(4). 457–460. 8 indexed citations

Minami, Toshiyuki, Takashi Kijima, Yasushi Otani, et al.. (2012). HER2 As Therapeutic Target for Overcoming ATP-Binding Cassette Transporter–Mediated Chemoresistance in Small Cell Lung Cancer. Molecular Cancer Therapeutics. 11(4). 830–841. 24 indexed citations

Shiroyama, Takayuki, Takashi Kijima, Kiyoshi Komuta, et al.. (2012). Phase II tailored S-1 regimen study of first-line chemotherapy in elderly patients with advanced and recurrent non-small cell lung cancer.. Journal of Clinical Oncology. 30(15_suppl). e18141–e18141. 1 indexed citations

Kijima, Takashi, Masahide Mori, Toshiyuki Minami, et al.. (2012). CXCL12 as a biological marker for the diagnosis of tuberculous pleurisy. Tuberculosis. 92(3). 248–252. 11 indexed citations

10.

Takahashi, Ryo, Haruhiko Hirata, Isao Tachibana, et al.. (2011). Early [18F]Fluorodeoxyglucose Positron Emission Tomography at Two Days of Gefitinib Treatment Predicts Clinical Outcome in Patients with Adenocarcinoma of the Lung. Clinical Cancer Research. 18(1). 220–228. 78 indexed citations

11.

Nakanishi, Kaori, Yoshito Takeda, Satoshi Tetsumoto, et al.. (2011). Involvement of Endothelial Apoptosis Underlying Chronic Obstructive Pulmonary Disease–like Phenotype in Adiponectin-null Mice: Implications for Therapy. American Journal of Respiratory and Critical Care Medicine. 183(9). 1164–1175. 57 indexed citations

12.

Kida, Hiroshi, Mitsuhiro Yoshida, Tetsuya Tomita, et al.. (2011). Recurrent allergic bronchopulmonary aspergillosis in a patient with rheumatoid arthritis treated with etanercept and tocilizumab. Modern Rheumatology. 21(6). 660–664. 12 indexed citations

13.

Tetsumoto, Satoshi, Akio Osa, Takashi Kijima, et al.. (2011). Two cases of leptomeningeal metastases from lung adenocarcinoma which progressed during gefitinib therapy but responded to erlotinib. International Journal of Clinical Oncology. 17(2). 155–159. 14 indexed citations

14.

Suzuki, Mayumi, Isao Tachibana, Yoshito Takeda, et al.. (2009). Tetraspanin CD9 Negatively Regulates Lipopolysaccharide-Induced Macrophage Activation and Lung Inflammation. The Journal of Immunology. 182(10). 6485–6493. 70 indexed citations

15.

Nagatomo, Izumi, Toru Kumagai, Tadahiro Yamadori, et al.. (2007). Gefitinib-Sensitive EGFR Lacking Residues 746–750 Exhibits Hypophosphorylation at Tyrosine Residue 1045, Hypoubiquitination, And Impaired Endocytosis. DNA and Cell Biology. 26(3). 178–185. 14 indexed citations

16.

He, Ping, Tetsuji Naka, Satoshi Serada, et al.. (2007). Proteomics‐based identification of α‐enolase as a tumor antigen in non‐small lung cancer. Cancer Science. 98(8). 1234–1240. 95 indexed citations

17.

Yoneda, Tsutomu, Toru Kumagai, Izumi Nagatomo, et al.. (2006). The Extracellular Domain of p185 ^c-neu Induces Density-Dependent Inhibition of Cell Growth in Malignant Mesothelioma Cells and Reduces Growth of Mesothelioma In Vivo. DNA and Cell Biology. 25(9). 530–540. 1 indexed citations

18.

Nagatomo, Izumi, Toru Kumagai, Tadahiro Yamadori, et al.. (2006). The Gefitinib-Sensitizing Mutant Epidermal Growth Factor Receptor Enables Transformation of a Mouse Fibroblast Cell Line. DNA and Cell Biology. 25(4). 246–251. 10 indexed citations

19.

Kida, Hiroshi, Mitsuhiro Yoshida, Koji Inoue, et al.. (2004). Protective effect of IL-6 on alveolar epithelial cell death induced by hydrogen peroxide. American Journal of Physiology-Lung Cellular and Molecular Physiology. 288(2). L342–L349. 53 indexed citations

20.

Arai, Toru, Masahide Mori, Hiroshi Kida, et al.. (1999). Effects of in vivo Soluble Selectin Gene Introduction on LPS-Induced Leukocyte Accumulation in the Murine Lung. Inflammation. 23(6). 523–534. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact